RU94023799A - Agent for suppurative wound local treatment
- Google Patents
Agent for suppurative wound local treatment
Info
Publication number
RU94023799A
RU94023799ARU94023799/14ARU94023799ARU94023799ARU 94023799 ARU94023799 ARU 94023799ARU 94023799/14 ARU94023799/14 ARU 94023799/14ARU 94023799 ARU94023799 ARU 94023799ARU 94023799 ARU94023799 ARU 94023799A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное общество закрытого типа "ФАРМ-Свет"filedCriticalАкционерное общество закрытого типа "ФАРМ-Свет"
Priority to RU94023799/14ApriorityCriticalpatent/RU94023799A/en
Publication of RU94023799ApublicationCriticalpatent/RU94023799A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: medicine, pharmacy. SUBSTANCE: agent has the following components, wt. -%: collagen, 0.995-0.950; and thymaline, 0.005-0.050. Agent can contain additionally antiseptic at amount up to 2% of collagen content and antibiotic at amount up to 20% of collagen content. Agent shows antiinflammatory, immunocorrecting actions and accelerates the suppurative wounds healing. EFFECT: enhanced effectiveness.
Claims (1)
Изобретение относится к химико-фармацевтической промышленности. Сущность изобретения состоит в создании нового лекарственного средства для местного лечения гнойных ран на основе коллагена и тималина при соотношении компонентов, мас. %: коллаген 0,996 - 0,950, тималин 0,006 - 0,050, которое может дополнительно содержать антисептик до 2% от содержания коллагена и антибиотик до 20% от содержания коллагена, проявляющего противовоспалительное, иммунокоррегирующее действие и ускоряющего заживление гнойных ран.The invention relates to the pharmaceutical industry. The invention consists in the creation of a new drug for local treatment of purulent wounds based on collagen and thymalin with a ratio of components, wt. %: collagen 0.996 - 0.950, thymalin 0.006 - 0.050, which may additionally contain an antiseptic up to 2% of the collagen content and an antibiotic up to 20% of the collagen content, which exhibits anti-inflammatory, immunocorrective effect and accelerates the healing of purulent wounds.
RU94023799/14A1994-06-271994-06-27Agent for suppurative wound local treatment
RU94023799A
(en)
Preparations for the application of anti-inflammatory agents, especially antiseptics and / or agents that promote wound healing in the lower respiratory tract
PHARMACEUTICAL COMPOSITION CONTAINING AN ASSOCIATION OF COLLAGEN AND AN ANTISEPTIC AND / OR ANTI-INFLAMMATORY ACTIVE SUBSTANCE AND ITS MANUFACTURING PROCEDURE.
Compositions containing lipoprotein associated coagulation inhibitor (LACI) for the manufacture of a medicament for the treatment of acute or chronic inflammation
(S) -adenosyl-L-methionine (SAMe) and its physiologically compatible salts for the treatment of reperfusion injury induced by transient lesion ischemia (Use of (S) -Adenosy-L-Methionine Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound